Baidu
map

2016生物医疗大数据论坛暨华理-梅斯联合研究中心成立仪式即将召开,敬请期待

2016-02-25 MedSci MedSci原创

为了推动生物医药大数据的发展,华东理工大学信息学院与上海梅斯医学,在上海大数据产业技术创新联盟,中国计算机学会大数据专委会指导下,成立了"生物医药开放链接大数据联合研究中心"旨在充分发挥双方优势,提供开放的中文基础生物医药数据,关联国内外已有的生物医药开放链接数据,搭建生物医疗大数据研究公共服务平台为行业发展尽绵薄之力。 为此,由华东理工大学信息学院与上海梅斯医学共同举办



为了推动生物医药大数据的发展,华东理工大学信息学院与上海梅斯医学,在上海市大数据联盟(筹),中国计算机学会大数据专委会指导下,成立了"生物医药开放链接大数据联合研究中心"旨在充分发挥双方优势,提供开放的中文基础生物医药数据,关联国内外已有的生物医药开放链接数据,搭建生物医疗大数据研究公共服务平台为行业发展尽绵薄之力。

为此,由华东理工大学信息学院与上海梅斯医学共同举办的“2016生物医疗大数据研讨会暨华理-梅斯联合研究中心成立”将于2016年3月12日在上海·华东理工大学召开。

此次会议将邀请政府、科研机构、企业学会协会等产业各方机构,围绕 "开放·链接·服务"主题,聚焦大数据开放与共享、数据关联,大数据关键技术与大数据在生物医药行业应用等话题展开研讨。此次会议还将举行华理-梅斯生物医药开放链接大数据研究中心成立仪式。


时间:2016312下午(12:00签到,14:00开幕式)
地点:上海·华东理工大学 逸夫楼

参会咨询:

张颖 
E-mail:Ying.zhang@bioon.com
Mt:13816470640

刘亚茹 
E-mail:Yaru.liu@medsci.cn
Mt:15921360132
 
小M好友,了解更多详情。
微信号:medsci_m

点击链接直接进入报名界面:http://www.bioon.com/z/2016huiyihd/Mt.html

会议主要内容介绍:

1.数据开放与共享

数据来源:生物样本库数据、碎片化的移动医疗数据、可穿戴医学设备与泛在数据、大型流行病学调查数据、临床登记数据库产生的病例资料数据 (临床注册登记研究推动医学进步与发展)、基因检测数据
医学大数据的开放与共享模式:公私合作新模式
互联网+生物医药:医学大数据收集与分析规范
端--云--端的数据新模态
 
2.数据平台与技术

电子病历文本处理技术异构大数据融合技术 
大数据统计分析、机器学习与数据挖掘
医疗数据可视化技术
生物医药数据表示标准
 
3.典型应用

大数据指导下的公共卫生服务健康大数据
整合与慢病管理基因测序大数据库与疾病的预测和预防
生物医疗大数据库在个性化治疗中的应用
智慧医疗中大数据解决方案
大数据加速医疗健康模式的整合
基于超级计算机的计算生物学

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1735943, encodeId=878d1e359431e, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Sep 09 23:56:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798500, encodeId=7e771e9850046, content=<a href='/topic/show?id=5ec569259a5' target=_blank style='color:#2F92EE;'>#生物医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69259, encryptionId=5ec569259a5, topicName=生物医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Tue Mar 22 19:56:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276777, encodeId=122212e6777f1, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Feb 27 01:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65654, encodeId=bf2065654e7, content=期待更多分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 19:01:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65634, encodeId=c40b6563481, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Feb 25 17:31:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1735943, encodeId=878d1e359431e, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Sep 09 23:56:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798500, encodeId=7e771e9850046, content=<a href='/topic/show?id=5ec569259a5' target=_blank style='color:#2F92EE;'>#生物医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69259, encryptionId=5ec569259a5, topicName=生物医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Tue Mar 22 19:56:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276777, encodeId=122212e6777f1, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Feb 27 01:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65654, encodeId=bf2065654e7, content=期待更多分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 19:01:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65634, encodeId=c40b6563481, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Feb 25 17:31:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1735943, encodeId=878d1e359431e, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Sep 09 23:56:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798500, encodeId=7e771e9850046, content=<a href='/topic/show?id=5ec569259a5' target=_blank style='color:#2F92EE;'>#生物医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69259, encryptionId=5ec569259a5, topicName=生物医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Tue Mar 22 19:56:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276777, encodeId=122212e6777f1, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Feb 27 01:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65654, encodeId=bf2065654e7, content=期待更多分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 19:01:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65634, encodeId=c40b6563481, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Feb 25 17:31:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
    2016-02-27 一闲
  4. [GetPortalCommentsPageByObjectIdResponse(id=1735943, encodeId=878d1e359431e, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Sep 09 23:56:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798500, encodeId=7e771e9850046, content=<a href='/topic/show?id=5ec569259a5' target=_blank style='color:#2F92EE;'>#生物医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69259, encryptionId=5ec569259a5, topicName=生物医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Tue Mar 22 19:56:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276777, encodeId=122212e6777f1, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Feb 27 01:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65654, encodeId=bf2065654e7, content=期待更多分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 19:01:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65634, encodeId=c40b6563481, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Feb 25 17:31:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
    2016-02-25 1de3b290m83(暂无匿称)

    期待更多分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1735943, encodeId=878d1e359431e, content=<a href='/topic/show?id=21be3492589' target=_blank style='color:#2F92EE;'>#医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34925, encryptionId=21be3492589, topicName=医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Fri Sep 09 23:56:00 CST 2016, time=2016-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798500, encodeId=7e771e9850046, content=<a href='/topic/show?id=5ec569259a5' target=_blank style='color:#2F92EE;'>#生物医疗大数据#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69259, encryptionId=5ec569259a5, topicName=生物医疗大数据)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ba8129, createdName=zhzhxiang, createdTime=Tue Mar 22 19:56:00 CST 2016, time=2016-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276777, encodeId=122212e6777f1, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Feb 27 01:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65654, encodeId=bf2065654e7, content=期待更多分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 19:01:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65634, encodeId=c40b6563481, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Thu Feb 25 17:31:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
    2016-02-25 huangwukui

    厉害

    0

Baidu
map
Baidu
map
Baidu
map